糖尿病多态性敏感性基因与胰岛素样生长因子2mRNA结合蛋白2之间的关联以及扩散型大B细胞淋巴瘤的风险
Weiling Zhou1, Qian Gao1, Cuiying He2
1Department of Endocrine and Metabolic Diseases, The Fourth Hospital of Hebei Medical University, Shijiazhuang, P.R. China.
Clinical Medicine Insights. Oncology
|October 12, 2023
概括
胰岛素样生长因子2 mRNA结合蛋白2 (IGF2BP2) 基因中的多态性与患扩散型大B细胞淋巴瘤 (DLBCL) 的风险增加有关. 这种遗传关联凸显了理解DLBCL发育的潜在新途径.
科学领域:
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- IGF2BP2基因中的多态化与各种癌症有关.
- 此前,IGF2BP2基因多态性在扩散性大B细胞淋巴瘤 (DLBCL) 发病中的作用尚未确定.
研究的目的:
- 调查IGF2BP2基因多态化与发展DLBCL的风险之间的关联.
- 为了确定特定的IGF2BP2变异是否有助于DLBCL易感性.
主要方法:
- 病例控制研究涉及295名DLBCL患者和331名健康对照.
- 聚合酶连锁反应-酶检测反应 (PCR-LDR) 用于基因组定型IGF2BP2多态.
- 对年龄,性别和BMI进行了调整,以评估风险.
主要成果:
- 在IGF2BP2中rs4402960多态 (GT,TT和T载体) 与DLBCL风险增加显著相关 (例如,TT基因型OR=2.00,P=.026).
- 在IGF2BP2中的rs1470579多态 (AC,CC和C载体) 也显示出与DLBCL风险升高的显著关联 (例如,CC基因型OR=2.18,P=.014).
结论:
- IGF2BP2基因多态性与患DLBCL的风险增加有关.
- 这些发现表明IGF2BP2是影响DLBCL易感性的潜在遗传因素.
相关概念视频
Genome-wide Association Studies-GWAS
13.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.5K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
RNA Splicing
56.4K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.4K


